Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 1
4(50.0%)
Phase 2
2(25.0%)
Early Phase 1
2(25.0%)
8Total
Phase 1(4)
Phase 2(2)
Early Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT07102459Phase 2Completed

An Efficacy and Safety Study of LTG-001 Following Abdominoplasty

Role: lead

NCT07110610Phase 1Recruiting

Phase 1 Single and Multiple Ascending Dose of LTG-321 in Healthy Participants

Role: lead

NCT06049095Phase 1Recruiting

A Phase 1 Single and Multiple Ascending Dose Study of LTG-001 Administered Orally in Healthy Participants

Role: lead

NCT07341152Phase 1Completed

A Study Comparing LTG-001 SDD Formulation To LTG-001 Crystalline Immediate Release Tablets In Healthy Participants

Role: lead

NCT06774625Phase 2Completed

This is a Study Evaluating the Efficacy and Safety of LTG-001 for Acute Pain After Surgical Removal of Impacted Third Molars

Role: lead

NCT06554574Phase 1Completed

A Phase 1 Single and Multiple Ascending Dose Study of LTG-305 Administered Orally in Healthy Participants

Role: lead

NCT06972212Early Phase 1Completed

Pharmacodynamic Study of 100mg Suzegtrigine vs Placebo in Healthy Male Adults

Role: lead

NCT06600607Early Phase 1Completed

Pharmacodynamic Study of 300mg Pregabalin vs Placebo in Healthy Male Adults

Role: lead

All 8 trials loaded